{"id":"W2343330905","doi":"10.1016/j.jval.2015.09.2481","title":"Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Hôpital Notre-Dame; Health Canada; Novartis (Canada)","funders":"","keywords":"Fingolimod; Natalizumab; Discontinuation; Medicine; Teriflunomide; Glatiramer acetate; Internal medicine; Multiple sclerosis; Pharmacy; Physical therapy; Family medicine; Disease; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006310072,0.0007850399,0.001401234,0.004745472,0.002300181,0.002365021,0.00303351,0.001470853,0.001997929],"category_scores_gemma":[0.0239709,0.001068532,0.003412531,0.01206377,0.0009397366,0.0009775218,0.001272291,0.001591921,0.0001988056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0243474,"about_ca_system_score_gemma":0.02683721,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9616714,"about_ca_topic_score_gemma":0.9414439,"domain_scores_codex":[0.9914004,0.001190673,0.001251847,0.001189732,0.003760192,0.001207302],"domain_scores_gemma":[0.9711984,0.005351363,0.01022541,0.001755229,0.009717098,0.001752516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001094721,0.00007788899,0.9935854,0.0001112765,0.001005596,0.00008329709,0.0003908294,0.0001920295,0.0001090475,0.0001479496,0.0006578857,0.002544108],"study_design_scores_gemma":[0.0001001263,0.00008316061,0.9976907,0.00004125517,0.0003873195,0.0001019783,0.0003225717,0.0006974155,0.00004917565,0.00002064495,0.0004759245,0.00002974708],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874672,0.002137489,0.0002133067,0.0002404187,0.00001731937,0.0001005372,0.008419987,0.00002118514,0.001382565],"genre_scores_gemma":[0.9924544,0.000832028,0.0003959055,0.000130577,0.00001881519,0.00005981176,0.005619138,0.0000174637,0.000471893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03832859,"threshold_uncertainty_score":0.1766536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1648320629122082,"score_gpt":0.3993700747735055,"score_spread":0.2345380118612973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}